SCHEMBL21589900

SCHEMBL21589900

COc1cc(F)cc(-c2ccc(C)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 4/20 0.50
▸ ABCB1 P08183 4/20 0.50
▸ BCR P11274 4/20 0.50
▸ ACHE P22303 2/20 0.46
▸ PGR P06401 2/20 0.46
▸ RXRA P19793 1/20 0.44
▸ HSD17B1 P14061 1/20 0.44
▸ HSD17B2 P37059 1/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2E1 P05181 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C8 P10632 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP4B1 P13584 1/20 0.44
▸ CYP2B6 P20813 1/20 0.44
▸ CYP3A5 P20815 1/20 0.44
▸ CYP2A7 P20853 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1045161 0.86 ABL1 (0.65) ABL1ABCB1BCRACHERXRA
SCHEMBL10049229 0.86 ABL1 (0.61) ABL1ABCB1BCRACHERXRA
SCHEMBL21586168 0.83 ABL1 (0.48) ABL1ABCB1BCRPGRRXRA
SCHEMBL6606854 0.82 CYP1A1 (0.55) ABL1ABCB1BCRPGRRXRA
SCHEMBL20804591 0.81 ACHE (0.52) ACHEPGRKMT2AMEN1
SCHEMBL265531 0.81 ACHE (0.52) ACHEPGRKMT2AMEN1
SCHEMBL20615604 0.79 ABL1 (0.59) ABL1ABCB1BCRRXRAHSD17B1
SCHEMBL2833469 0.79 NPC1 (0.57) ABL1ABCB1BCRHSD17B1HSD17B2
SCHEMBL27852526 0.79 ABL1 (0.44) ABL1ABCB1BCRPGRRXRA
SCHEMBL25365883 0.79 ABL1 (0.44) ABL1ABCB1BCRPGRRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023004240-A1 MACROCYLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-01-26 — — WO disclosed
WO-2019234405-A1 COMPOUNDS USEFUL IN THE TREATMENT OF DISORDERS ASSOCIATED WITH MUTANT RAS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2019-12-12 — — WO disclosed
Send feedback